H-89-dihydrochloride-Protein-kinase-inhibitor-H-89-dihydrochloride-DataSheet-MedChemExpress_第1页
H-89-dihydrochloride-Protein-kinase-inhibitor-H-89-dihydrochloride-DataSheet-MedChemExpress_第2页
H-89-dihydrochloride-Protein-kinase-inhibitor-H-89-dihydrochloride-DataSheet-MedChemExpress_第3页
全文预览已结束

下载本文档

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、Hotline: 400-820-3792Inhibitors Agonists Screening Librarieswww.MedChemEH-89 dihydrochlorideCat. No.: HY-15979ACAS No.: 130964-39-5Synonyms: Protein kinase inhibitor H-89 dihydrochloride分式: CHBrClNOS分量: 519.28作靶点: PKA; Autophagy作通路: Protein Tyrosine Kinase/RTK; Stem Cell/Wnt; Autophagy储存式: Powder -2

2、0C 3 years4C 2 yearsIn solvent -80C 6 months-20C 1 month溶解性数据体外实验 DMSO : 50 mg/mL (96.29 mM)* means soluble, but saturation unknown.Mass Solvent1 mg 5 mg 10 mg Concentration制备储备液1 mM 1.9257 mL 9.6287 mL 19.2574 mL5 mM 0.3851 mL 1.9257 mL 3.8515 mL10 mM 0.1926 mL 0.9629 mL 1.9257 mL请根据产品在不同溶剂中的溶解度,选择

3、合适的溶剂配制储备液,并请注意储备液的保存式和期限。BIOLOGICAL ACTIVITY物活性 H-89 dihydrochloride种有效、选择性的 cAMP 依赖性蛋激酶A (PKA) 抑制剂,IC50 值为 48 nM。也可轻微抑制 PKG,PKC,酪蛋激酶活性。IC50 & Target IC50: 48 nM (protein kinase A)1/3 Master of Small Molecules 您边的抑制剂师www.MedChemE体外研究 H-89 inhibits protein kinase A, in competitive fashion against AT

4、P. H-89 causes a dose-dependent inhibitionof the forskolin-induced protein phosphorylation, with no decrease in intracellular cyclic AMP levels in PC12Dcells. H-89 significantly inhibits the forskolin-induced neurite outgrowth from PC12D cells. H-89 (30 M)inhibits significantly cAMP-dependent histon

5、e IIb phosphorylation activity in PC12D cell lysates 1. H-89 (1-2M) significantly slows the repriming rate in rat skinned fibres, most likely due to it deleteriously affecting theT-system potential. H-89 (10-100 M) inhibits net Ca2+ uptake by the SR and affectes the Ca2+-sensitivity ofthe contractil

6、e apparatus in rat skinned fibres 2.体内研究 H-89 (0.2 mg/100g, i.p.) significantly increases seizure latency and threshold in PTZ-treated animals. H-89(0.05, 0.2 mg/100 g, i.p.) prevents the epileptogenic activity of bucladesine (300 nM) with significant increaseof seizure latency and seizure threshold

7、 3.PROTOCOLKinase Assay 1 Kinase activities are assayed at 30C for 2-5 min by measuring the transfer of 32P from -32PATP tosubstrates. The reaction is terminated by adding 1 mL of 20% trichloroacetic acid, following the addition of100 g of bovine serum albumin as a carrier protein. The sample is cen

8、trifuged at 3000 rpm for 10 min, thepellet is resuspended in 5% trichloroacetic acid solution, the final pellet is dissolved in 1 mL of 1 N NaOH andthe radioactivity is measured in a liquid scintillation counter.MCE has not independently confirmed the accuracy of these methods. They are for referenc

9、e only.Cell Assay 1 After 48 h in culture, PCl2D cells are cultured in test medium containing 30 M H-89 for 1 h and thenexposed to fresh medium that contained both 10 M forskolin and 30 M H-89. Cells are scraped off with arubber policeman and sonicated in the presence of 0.5 mL of 6% trichloroacetic

10、 acid. To extracttrichloroacetic acid, 2 mL of petroleum ether is added, the preparation mixed and centrifuged at 3000 rpm for10 min. After aspiration of the upper layer, the residue sample solution is used for determination.MCE has not independently confirmed the accuracy of these methods. They are

11、 for reference only.Animal Male albino mice weighing 20-25 g are obtained. Pentoxifylline (25, 50, 100 mg/kg), bucladesine (50, 100,Administration 1 300 nM/mouse) and H-89 (0.05, 0.1, 0.2 mg/100 g) are administered intraperitoneally (i.p.) 30 min beforeintravenous (i.v.) infusion of PTZ. In combinat

12、ion groups, the first and second components are injected 45and 30 min before PTZ infusion. In all groups, the respective control animalsreceive an appropriate volume ofvehicle. For the i.v. infusion, the needle is inserted into the lateral tail vein, fixed to the tail vein by a narrowpiece of adhesi

13、ve tape, and the animal is allowed to move freely. PTZ solution is infused at a concentrationrate of 1 mL/min.MCE has not independently confirmed the accuracy of these methods. They are for reference only.户使本产品发表的科研献 Aging Cell. 2018 Jun;17(3):e12754. J Neurosci. 2016 Oct 12;36(41):10560-10573. Agin

14、g (Albany NY). 2018 Jul 24;10(7):1722-1744. Int J Mol Sci. 2018 Oct 7;19(10). pii: E3053.2/3 Master of Small Molecules 您边的抑制剂师www.MedChemE Front Pharmacol. 2018 Apr 12;9:362.See more customer validations on HYPERLINK / www.MedChemEREFERENCES1. Chijiwa T, et al. Inhibition of forskolin-induced neurit

15、e outgrowth and protein phosphorylation by a newly synthesized selective inhibitor ofcyclic AMP-dependent protein kinase, N-2-(p-bromocinnamylamino)ethyl-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytomacells. J Biol Chem. 1990 Mar 25;265(9):5267-72.2. Blazev R, et al. Effects of the PKA inhibitor H-89 on excitation-contraction coupling in skinned and intact skeletal muscle fibres. J MuscleRes Cell Motil. 2001;22(3):277-86.3. Hosseini-Zare MS, et al. Effects of pentoxifylline and H-89 on epileptogenic activity of bucladesine in pentylenetetrazol-treated mice. EurJ

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论